202 related articles for article (PubMed ID: 26558136)
1. Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Patil A; Patil K; Tupsakhare S; Gabhane M; Sonune S; Kandalgaonkar S
Scientifica (Cairo); 2015; 2015():135298. PubMed ID: 26558136
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
4. Expression of podoplanin in oral premalignant and malignant lesions and its potential as a biomarker.
Logeswari J; Malathi N; Thamizhchelvan H; Sangeetha N; Nirmala SV
Indian J Dent Res; 2014; 25(3):305-10. PubMed ID: 25098985
[TBL] [Abstract][Full Text] [Related]
5. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
Parhar S; Kaur H; Vashist A; Verma S
Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma.
A G D; Janardanan-Nair B; B R V
J Clin Exp Dent; 2017 Dec; 9(12):e1418-e1424. PubMed ID: 29410757
[TBL] [Abstract][Full Text] [Related]
7. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in oral leukoplakia: tumorigenic role.
de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Mast Cell and Angiogenesis in Oral Lichen Planus, Dysplasia (Leukoplakia), and Oral Squamous Cell Carcinoma.
Sundararajan A; Muthusamy R; Gopal Siva K; Harikrishnan P; Kumar SCK; Rathinasamy SK
Rambam Maimonides Med J; 2021 Apr; 12(2):. PubMed ID: 33938803
[TBL] [Abstract][Full Text] [Related]
10. An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Patel NR; Jain L; Mahajan AM; Hiray PV; Shinde SS; Patel PA
Indian J Otolaryngol Head Neck Surg; 2019 Dec; 71(4):435-441. PubMed ID: 31750100
[TBL] [Abstract][Full Text] [Related]
11. Expression of Podoplanin in Different Grades of Oral Squamous Cell Carcinoma.
Prasad B; Kashyap B; Babu GS; Kumar GR; Manyam R
Ann Med Health Sci Res; 2015; 5(4):299-304. PubMed ID: 26229720
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
Pazhani J; Chanthu K; Jayaraman S; Varun BR
J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
[TBL] [Abstract][Full Text] [Related]
13. A Preliminary Study of the Role of Endothelial-Mesenchymal Transitory Factor SOX 2 and CD147 in the Microvascularization of Oral Squamous Cell Carcinoma.
Zisis V; Anastasiadou PA; Poulopoulos A; Vahtsevanos K; Paraskevopoulos K; Andreadis D
Cureus; 2024 Jan; 16(1):e52265. PubMed ID: 38352102
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Srinivasan V; Shyam N; Kumar GK; Narayen V; Konda P; Swetha Rani K
Cureus; 2023 May; 15(5):e38467. PubMed ID: 37273383
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Study of the Cancer Stem Cells' Biomarker CD147 in Leukoplakia: Dysplasia and Squamous Cell Carcinoma of Oral Epithelial Origin.
Zisis V; Andreadis D; Anastasiadou P; Vahtsevanos K; Akrivou M; Vizirianakis IS; Poulopoulos A
Cureus; 2023 May; 15(5):e38807. PubMed ID: 37303447
[TBL] [Abstract][Full Text] [Related]
16. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis.
Mei Y; Zhang P; Zuo H; Clark D; Xia R; Li J; Liu Z; Mao L
Oncogene; 2014 Jul; 33(29):3839-50. PubMed ID: 23975429
[TBL] [Abstract][Full Text] [Related]
17. Expression of Podoplanin in Laryngeal Squamous Cell Carcinoma and Dysplasia.
Ibrahim BB; Salem MM; Khairy RA; Al Gunaid RAR
J Clin Diagn Res; 2017 May; 11(5):EC31-EC35. PubMed ID: 28658769
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin expression in oral leukoplakia─a prospective study.
Grochau KJ; Safi AF; Drebber U; Grandoch A; Zöller JE; Kreppel M
J Craniomaxillofac Surg; 2019 Mar; 47(3):505-509. PubMed ID: 30638740
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma.
Sravya T; Sivaranjani Y; Rao GV
J Oral Maxillofac Pathol; 2016; 20(1):71-7. PubMed ID: 27194865
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
